Shardul Amarchand Mangaldas advises Krishna Institute of Medical Sciences on ₹600 crore preferential allotment of warrants

M&A / JV 30 Sept 2026· ₹600 cr · Announced· ◔ Reported

Krishna Institute of Medical Sciences Limited has made a preferential allotment of fully convertible warrants aggregating to approximately ₹600 crore in favour of Promoters Dr. Abhinay Bollineni and Mr. Adwik Bollineni and Promoter Group Bharas Ventures LLP. Shardul Amarchand Mangaldas & Co advised Krishna Institute of Medical Sciences on this transaction.

CounselShardul Amarchand Mangaldas
SectorIndustrials
Value₹600 cr

Sources

Open in the live tracker →

Related deals